HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Blood
Globulin, Serum
Pyruvate Kinase, Erythrocytes
Tissue Transglutaminase (tTG) Antibody, IgA, IgG
Compatibility Tests (Crossmatch), ABO, Rh Typing
Tissue Transglutaminase (tTG) Antibody, IgA
Porphobilinogen, Urine
Chronic Fatigue Syndrome Diagnostic Panel
Creatinine, with Estimated eGFR, Serum
LDS
Sign up
Log in
LDS
/
Medical Tests
/
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
Medical Test
Reference Ranges
Access to
VENTANA® MET (SP44) RxDx IHC Assay for non-squamous, non-small cell lung cancer (NSQ-NSCLC)
is restricted.
Sign up now
Loading...